Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.

Journal of thrombosis and haemostasis : JTH - 1 Jun 2015

Ades S, Kumar S, Alam M, Goodwin A, Weckstein D, Dugan M, Ashikaga T, Evans M, Verschraegen C, Holmes C E

Abstract excerpt

BACKGROUND: Patients with metastatic colon cancer (mCRC) are at increased risk of venous thromboembolism (VTE). Limited preclinical data suggest that the oncogene (KRAS) mutational status of the tumor represents a plausible clinical link to systemic hypercoagulability in cancer patients. OBJECTIVES: To determine if a tumor genetic characteristic, KRAS mutational status, is associated with an increased risk of VTE...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kaplan-Meier Estimate
Share to Logistic Models

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Predictive Value of Tests

Share to Proto-Oncogene Proteins p21(ras)

Share to Pulmonary Embolism

Share to Venous Thromboembolism

Share to Venous Thrombosis

Source

Identifiers

PMID: 25809746
DOI: 10.1111/jth.12910

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.PMID 25809746Read ↗

The Role of KRAS Mutation in Colorectal Cancer-Associated Thrombosis.Semantic proximity Read ↗

Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.Semantic proximity Read ↗

Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid TumorsSemantic proximity Read ↗

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.Semantic proximity Read ↗

Associations of tumor somatic mutations with cancer-associated venous thromboembolism.Semantic proximity Read ↗

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.Semantic proximity Read ↗

Associations of tumour somatic mutations with cancer-associated venous thromboembolismSemantic proximity Read ↗

Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.Semantic proximity Read ↗

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.